COVID-19 associated rhino-orbital-cerebral mucormycosis with underlying diabetes mellitus

2022

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.23950/jcmk/12725
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Introduction: Since the beginning of the COVID-19 pandemic, there has been an increase in opportunistic infections such as mucormycosis, which is of some concern given the fairly rapid spread. The development of immunosuppression associated with COVID-19, coupled with the presence of comorbidities that exacerbate the progression of the disease and in some cases lead to a fatal outcome, plays an important role in this. Case presentation: We have examined a real case of rhino-orbital-cerebral mucormycosis in comparison with earlier published contemporary studies on epidemiology, clinical manifestations, and risk factors. Autopsy materials of nasal mucosa, eye socket, brain of a patient with COVID-19 associated with diabetes mellitus have been subjected to a histological study. Conclusion: The presented case demonstrates a unique pathomorphological pattern of rhino-orbital-cerebral mucormycosis, first registered in Kazakhstan and of great interest in the world practice.